National Medical Care Co. announces the Results of the Ordinary General Assembly Meeting (First Meeting)

Element ListExplanation
Introduction The Board of Directors of the National Medical Care Company is pleased to announce the results of voting on the agenda items for the Ordinary General Assembly meeting (first meeting)
City and Location of the General Assembly's Meeting The company's headquarter in Riyadh, by means of modern technology
Date of the General Assembly's Meeting 2022-09-06 Corresponding to 1444-02-10
Time of the General Assembly's Meeting 18:30
Percentage of Attending Shareholders 56.07%
Names of the Board of Directors' Members Present at the General Assembly's Meeting and Names of the Absentees The meeting was attended by the following board members:

• Saad Abdulmohsen Alfadly _ Chairman

• Michael Davis _ Deputy Chairman

• Faraj Saad Al-Gabani

• Bader Fahad AlAthel

• May Mohammed Al-Hoshan

• Sami Suliman AlKashan

• Bashar Abdulaziz Abalkhail

• Ahmed Wazaa Alqahtani

• Mashhoor Mohammed Al-Obeikan

Names of the Chairmen of the Committees Present at the General Assembly's Meeting or Members of such Committees Attending on Their Behalf The meeting was attended by the following heads of committees:

• Michael Davis - Chairman of the Executive Committee

• Bashar Abdulaziz Abalkhail - Chairman of the Nominations and Remuneration Committee

• Mashhoor Mohammed Al-Obeikan– Chairman of the Audit Committee

Voting Results on the Items of the General Assembly's Meeting Agenda's 1. Approval on voting on the election of board members from among candidates for the next session, which starts on 15-09-2022 and ends on 14-09-2025 for a period of three years:

1) Saad Abdulmohsen AlFadly

2) Micheal Davis

3) Ahmed Wazaa AlQahtani

4) Sami Suliman AlKashan

5) Abdulaziz Saleh AlObaid

6) Faraj Saad AlGabani

7) Bashar Abdulaziz Abalkhail

8) May Mohammed AlHoshan

9) Bader Fahad AlAthel

2. Approval of the formation of the Audit Committee and define its tasks, work controls and remuneration for its members for the new session starting from 15-09-2022 until the end of the session on 14-09-2025, noting that the candidates (attached with their CVs) are:

1) Sami Suliman AlKashan (independent member)

2) 2-Bashar Abdulaziz Abalkail(independent member)

3) 3-Faraj saad Al-Gabani (non-executive member)

3. Approval of the delegating the Board of Directors for its session starting from 15-09-2022 AD with validity to the authority of the Ordinary General Assembly with the authorization contained in Paragraph (1) of Article 71 of the Companies Law, for a period of one year from the date of approval of the General Assembly or until the end of the delegated Board of Directors session, whichever is earlier, in accordance with the conditions set forth in The controls and regulatory procedures issued in implementation of the Companies Law for Listed Joint Stock Companies.

The Capital Market Authority and Saudi Exchange take no responsibility for the contents of this disclosure, make no representations as to its accuracy or completeness, and expressly disclaim any liability whatsoever for any loss arising from, or incurred in reliance upon, any part of this disclosure, and the issuer accepts full responsibility for the accuracy of the information contained in it and confirms, having made all reasonable enquiries, that to the best of their knowledge and belief, there are no other facts or information the omission of which would make the disclosure misleading, incomplete or inaccurate.

Company Profile


Company Profile


Last Price Net Change
72.4 0.8 (+1.12%)
Value Traded (SAR) Volume Traded
910,922.5 12,706